Arne Brecht
About
Arne Brecht is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology.
According to data from OpenAlex, Arne Brecht has authored 19 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 8 papers in Public Health, Environmental and Occupational Health and 6 papers in Oncology. Recurrent topics in Arne Brecht's work include Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Acute Lymphoblastic Leukemia research (8 papers). Arne Brecht is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Acute Lymphoblastic Leukemia research (8 papers). Arne Brecht collaborates with scholars based in Germany, France and Israel. Arne Brecht's co-authors include Arnon Nagler, Mohamad Mohty, Myriam Labopin, Jürgen Finke, Nicolaus Kröger, Matthias Stelljes, Arnold Ganser, Bipin N. Savani, Johanna Tischer and Gerhard Ehninger and has published in prestigious journals such as Blood, European Journal of Cancer and British Journal of Haematology.
In The Last Decade
Arne Brecht
17 papers receiving 286 citations
Peers
Arne Brecht
Myriam Labopin France
Christophe Peczynski France
Sanghee Hong United States
Kaito Harada Japan
Jérémy Delage France
Elisa Mauro Italy
Damianos Sotiropoulos Greece
A. Birgitta Versluijs Netherlands
Zina Chir France
Anne S. Renteria United States
Citations per year, relative to Arne Brecht Arne Brecht (= 1×)
peers
Myriam Labopin
Countries citing papers authored by Arne Brecht
Since
Specialization
Citations
This map shows the geographic impact of Arne Brecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Brecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Brecht more than expected).
Fields of papers citing papers by Arne Brecht
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Arne Brecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Brecht. The network helps show where Arne Brecht may publish in the future.
Co-authorship network of co-authors of Arne Brecht
This figure shows the co-authorship network connecting the top 25 collaborators of Arne Brecht. A scholar is included among the top collaborators of Arne Brecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Brecht. Arne Brecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Maffini, Enrico, Myriam Labopin, Nicolaus Kröger, et al.. (2024). Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 59(7). 983–990.
2.
Gagelmann, Nico, Matthias Stelljes, Igor Wolfgang Blau, et al.. (2024). Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantation. American Journal of Hematology. 99(8). 1540–1549.
3.
Hamed, Rama Al, Myriam Labopin, Wolfgang Bethge, et al.. (2022). Amsa/ARA-C Followed By TBI 4 Gy or High Dose Chemotherapy Conditioning Regimens in Primary Refractory AML - Significantly Worse Outcomes in Younger Patients Conditioned with 4 Gy TBI. Blood. 140(Supplement 1). 10455–10457.
4.
Bazarbachi, Abdul Hamid, Myriam Labopin, Nicolaus Kröger, et al.. (2021). Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 21(12). 831–840.
5.
Rodríguez‐Arbolí, Eduardo, Myriam Labopin, Johanna Tischer, et al.. (2020). FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 26(11). 2165–2173.
6.
Labopin, Myriam, Giorgia Battipaglia, Dietrich W. Beelen, et al.. (2020). The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP ) of the European group for blood and marrow transplantation (EBMT) . American Journal of Hematology. 96(1). 40–50.
7.
Heinicke, Thomas, Myriam Labopin, Emmanuelle Polge, et al.. (2020). Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia – a study of the Acute Leukemia Working Party of the EBMT. Leukemia & lymphoma. 62(2). 399–409.
8.
Ringdén, Olle, Ariane Boumendil, Myriam Labopin, et al.. (2019). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 25(10). 1975–1983.
9.
Saraceni, Francesco, Myriam Labopin, Arne Brecht, et al.. (2019). Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Journal of Hematology & Oncology. 12(1). 44–44.
10.
Nagler, Arnon, Myriam Labopin, Bhagirathbhai Dholaria, et al.. (2019). Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. British Journal of Haematology. 186(5). 767–776.
11.
Sheth, Vipul, Myriam Labopin, Jonathan Canaani, et al.. (2018). Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis. Bone Marrow Transplantation. 54(4). 531–539.
12.
Heinicke, Thomas, Myriam Labopin, Christoph Schmid, et al.. (2018). Reduced Relapse Incidence with FLAMSA–RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 24(11). 2224–2232.
13.
Santoro, Nicole, Myriam Labopin, Federica Giannotti, et al.. (2018). Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT. Journal of Hematology & Oncology. 11(1). 55–55.
14.
Brissot, Éolia, Myriam Labopin, Gerhard Ehninger, et al.. (2018). Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT. Haematologica. 104(3). 524–532.
15.
Labopin, Myriam, Dietrich W. Beelen, Johanna Tischer, et al.. (2018). The Impact of Cytogenetics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Survey from the Acute Leukemia Working Party (ALWP) of EBMT. Blood. 132(Supplement 1). 4639–4639.
16.
Poiré, Xavier, Myriam Labopin, Emmanuelle Polge, et al.. (2017). Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. 103(2). 256–265.
17.
Brecht, Arne, et al.. (2007). Generalisierte Lymphadenitis mit Hashimoto-Thyreoiditis. DMW - Deutsche Medizinische Wochenschrift. 132(16). 874–877.
18.
Hartung, G., Ralf‐Dieter Hofheinz, Dieter Buchheidt, et al.. (2000). Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial. Oncology Research and Treatment. 23(5). 444–447.
19.
Hofheinz, Ralf‐Dieter, G. Hartung, A. Wein, et al.. (1999). Phase-II-study of a 24-h infusion with 5-fluorouracil (5-FU) and simultaneous sodium-folinic acid in the first-line-treatment of advanced colorectal cancer: interim analysis. European Journal of Cancer. 35. S81–S81.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Myriam Labopin Breakdown of academic impact, for papers by Christophe Peczynski Breakdown of academic impact, for papers by Sanghee Hong Breakdown of academic impact, for papers by Kaito Harada Breakdown of academic impact, for papers by Jérémy Delage Breakdown of academic impact, for papers by Elisa Mauro Breakdown of academic impact, for papers by Damianos Sotiropoulos Breakdown of academic impact, for papers by A. Birgitta Versluijs Breakdown of academic impact, for papers by Zina Chir Breakdown of academic impact, for papers by Anne S. Renteria